Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Community-acquired pneumonia

J Rello1

  • 1Hospital de Sabadell, Barcelona, Spain.

Current Opinion in Pulmonary Medicine
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Community-acquired pneumonia (CAP) research highlights improved understanding of its epidemiology and outcomes. Future research should focus on cost-effective treatments and earlier diagnoses for severe cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytotoxicity and virulence attributes of <i>Pseudomonas aeruginosa</i> isolates from case reports of patients with necrotizing pneumonia.

Respiratory medicine case reports·2025
Same author

Medicina intensiva·2024
Same author

Optimization of antimicrobial prescription in the hospital.

European journal of internal medicine·2022
Same author

COVID-19 cutaneous manifestations in pediatric patients: 24 multisystem inflammatory syndrome in children and six Kawasaki disease cases.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Protecting adults at risk of pneumococcal infection and influenza from exposure to SARS-CoV-2.

Human vaccines & immunotherapeutics·2021
Same author

Secondary infections in mechanically ventilated patients with COVID-19: An overlooked matter?

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2021
Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026
Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026
Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
See all related articles

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Clinical Microbiology

Background:

  • Community-acquired pneumonia (CAP) remains a significant clinical challenge with ongoing research into its various aspects.
  • Recent literature has expanded knowledge regarding CAP epidemiology and patient outcomes.
  • Advances in molecular biology offer potential for earlier diagnosis of specific CAP etiologies.

Purpose of the Study:

  • To review recent advancements in understanding and managing community-acquired pneumonia.
  • To highlight the focus on treatment strategies aimed at cost reduction and maintained clinical efficacy.
  • To identify areas requiring further investigation in CAP research.

Main Methods:

  • Literature review of recent publications on community-acquired pneumonia.

Related Experiment Videos

  • Analysis of studies focusing on epidemiological data and patient outcomes.
  • Evaluation of research on diagnostic technologies and treatment approaches.

    • Main Results:

    • Significant contributions to the understanding of CAP epidemiology and outcomes have been made.
    • Emerging molecular diagnostic tools show promise for identifying etiologies in severe CAP cases.
    • Current research trends emphasize treatment strategies balancing cost-effectiveness with clinical efficacy.

    Conclusions:

    • While knowledge of CAP has advanced, particularly in treatment, further research is essential.
    • Earlier diagnosis through molecular techniques could improve management of severe CAP.
    • Continued investigation is needed to optimize cost-effective and clinically effective CAP management strategies.